OBJECTIVE: Cortical myelin can be severely affected in patients with demyelinating disorders of the central nervous system. However, the functional implication of cortical demyelination remains elusive. In this study, we investigated whether cortical myelin influences cortical spreading depression (CSD). METHODS: CSD measurements were performed in rodent models of toxic and autoimmune induced cortical demyelination, in neuregulin-1 type I transgenic mice displaying cortical hypermyelination, and in glial fibrillary acidic protein-transgenic mice exhibiting pronounced astrogliosis. RESULTS: Cortical demyelination, but not astrogliosis or inflammation per se, was associated with accelerated CSD. In contrast, hypermyelinated neuregulin-1 type I transgenic mice displayed a decelerated CSD propagation. INTERPRETATION: Cortical myelin may be crucially involved in the stabilization and buffering of extracellular ion content that is decisive for CSD propagation velocity and cortical excitability, respectively. Our data thus indicate that cortical involvement in human demyelinating diseases may lead to relevant alterations of cortical function.
OBJECTIVE: Cortical myelin can be severely affected in patients with demyelinating disorders of the central nervous system. However, the functional implication of cortical demyelination remains elusive. In this study, we investigated whether cortical myelin influences cortical spreading depression (CSD). METHODS: CSD measurements were performed in rodent models of toxic and autoimmune induced cortical demyelination, in neuregulin-1 type I transgenic mice displaying cortical hypermyelination, and in glial fibrillary acidic protein-transgenic mice exhibiting pronounced astrogliosis. RESULTS:Cortical demyelination, but not astrogliosis or inflammation per se, was associated with accelerated CSD. In contrast, hypermyelinated neuregulin-1 type I transgenic mice displayed a decelerated CSD propagation. INTERPRETATION: Cortical myelin may be crucially involved in the stabilization and buffering of extracellular ion content that is decisive for CSD propagation velocity and cortical excitability, respectively. Our data thus indicate that cortical involvement in humandemyelinating diseases may lead to relevant alterations of cortical function.
Authors: Katharina Eikermann-Haerter; Izumi Yuzawa; Tao Qin; Yumei Wang; Kwangyeol Baek; Young Ro Kim; Ulrike Hoffmann; Ergin Dilekoz; Christian Waeber; Michel D Ferrari; Arn M J M van den Maagdenberg; Michael A Moskowitz; Cenk Ayata Journal: J Neurosci Date: 2011-04-13 Impact factor: 6.167
Authors: Paula Catirina Germano Magalhães; Ricardo Abadie-Guedes; Manoel Augusto Barbosa da Costa Mendonça; Aline Duarte de Souza; Rubem Carlos Araújo Guedes Journal: Metab Brain Dis Date: 2018-12-13 Impact factor: 3.584
Authors: Katrin Weier; Brenda Banwell; Antonio Cerasa; D Louis Collins; Anne-Marie Dogonowski; Hans Lassmann; Aldo Quattrone; Mohammad A Sahraian; Hartwig R Siebner; Till Sprenger Journal: Cerebellum Date: 2015-06 Impact factor: 3.847
Authors: Dan Kaufmann; Jeremy J Theriot; Jekaterina Zyuzin; C Austin Service; Joshua C Chang; Y Tanye Tang; Vladimir B Bogdanov; Sylvie Multon; Jean Schoenen; Y Sungtaek Ju; K C Brennan Journal: J Cereb Blood Flow Metab Date: 2016-01-01 Impact factor: 6.200